Asterias Biotherapeutics, Inc. Research and Development Expense
Asterias Biotherapeutics, Inc. reported Research and Development Expense of $3.51 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2018-11-09
- Asterias Biotherapeutics, Inc. research and development expense for the quarter ending 2018-09-30 was $3.51M, a 47.01% decline year-over-year.
- Asterias Biotherapeutics, Inc. research and development expense for the quarter ending 2018-06-30 was $3.62M, a 48.21% decline year-over-year.
- Asterias Biotherapeutics, Inc. research and development expense for the quarter ending 2018-03-31 was $3.63M, a 45.04% decline year-over-year.
- Asterias Biotherapeutics, Inc. research and development expense for the quarter ending 2017-12-31 was $6.43M, a 18.28% decline year-over-year.
- Asterias Biotherapeutics, Inc. research and development expense for fiscal 2017 was $26.64M, a 4.61% increase from fiscal 2016.
- Asterias Biotherapeutics, Inc. research and development expense for fiscal 2016 was $25.47M, a 47.03% increase from fiscal 2015.
- Asterias Biotherapeutics, Inc. research and development expense for fiscal 2015 was $17.32M, a 30.14% increase from fiscal 2014.
- Asterias Biotherapeutics, Inc. research and development expense for fiscal 2014 was $13.31M, a 208.17% increase from fiscal 2013.
| Period end | Research and Development Expense 0 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 15 month | Research and Development Expense 18 month | Research and Development Expense 21 month | Research and Development Expense 24 month | Research and Development Expense 27 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $3.51M 10-Q · filed 2018-11-09 | $7.13M derived: sum of 2 quarters · filed 2018-11-09 | $10.75M 10-Q · filed 2018-11-09 | $17.19M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-06-30 | $3.62M 10-Q · filed 2018-08-09 | $7.24M 10-Q · filed 2018-08-09 | $13.68M derived: sum of 3 quarters · filed 2018-08-09 | $20.30M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-03-31 | $3.63M 10-Q · filed 2018-05-09 | $10.06M derived: sum of 2 quarters · filed 2018-05-09 | $16.68M derived: sum of 3 quarters · filed 2018-11-09 | $23.67M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-12-31 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $13.06M derived: sum of 2 quarters · filed 2018-11-09 | $20.04M derived: sum of 3 quarters · filed 2018-11-09 | $26.64M 10-K · filed 2018-03-15 | ||||||||||
| 2017-09-30 | $6.62M 10-Q · filed 2018-11-09 | $13.61M derived: sum of 2 quarters · filed 2018-11-09 | $20.21M 10-Q · filed 2018-11-09 | $28.08M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-06-30 | $6.98M 10-Q · filed 2018-08-09 | $13.58M 10-Q · filed 2018-08-09 | $21.45M derived: sum of 3 quarters · filed 2018-08-09 | $26.69M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||
| 2017-03-31 | $6.60M 10-Q · filed 2018-05-09 | $14.47M derived: sum of 2 quarters · filed 2018-05-09 | $19.70M derived: sum of 3 quarters · filed 2018-05-09 | $25.72M derived: sum of 4 quarters · filed 2018-05-09 | ||||||||||
| 2016-12-31 | $7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $13.11M derived: sum of 2 quarters · filed 2018-03-15 | $19.12M derived: sum of 3 quarters · filed 2018-03-15 | $25.47M 10-K · filed 2018-03-15 | ||||||||||
| 2016-09-30 | $5.23M 10-Q · filed 2017-11-14 | $11.25M derived: sum of 2 quarters · filed 2017-11-14 | $17.59M 10-Q · filed 2017-11-14 | $23.00M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2016-06-30 | $6.02M 10-Q · filed 2017-08-14 | $12.36M 10-Q · filed 2017-08-14 | $17.77M derived: sum of 3 quarters · filed 2018-03-15 | $22.39M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2016-03-31 | $6.34M 10-Q · filed 2017-05-11 | $11.75M derived: sum of 2 quarters · filed 2018-03-15 | $16.38M derived: sum of 3 quarters · filed 2018-03-15 | $20.07M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2015-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $10.03M derived: sum of 2 quarters · filed 2018-03-15 | $13.73M derived: sum of 3 quarters · filed 2018-03-15 | $17.32M 10-K · filed 2018-03-15 | ||||||||||
| 2015-09-30 | $4.63M 10-Q · filed 2016-11-14 | $8.32M derived: sum of 2 quarters · filed 2016-11-14 | $11.92M 10-Q · filed 2016-11-14 | $17.32M derived: sum of 4 quarters · filed 2017-03-28 | ||||||||||
| 2015-06-30 | $3.70M 10-Q · filed 2016-08-15 | $7.29M 10-Q · filed 2016-08-15 | $12.69M derived: sum of 3 quarters · filed 2017-03-28 | $15.26M derived: sum of 4 quarters · filed 2017-03-28 | ||||||||||
| 2015-03-31 | $3.59M 10-Q · filed 2016-05-16 | $3.59M 10-Q · filed 2015-05-08 | $8.99M derived: sum of 2 quarters · filed 2017-03-28 | $11.56M derived: sum of 3 quarters · filed 2017-03-28 | $14.30M derived: sum of 4 quarters · filed 2017-03-28 | |||||||||
| 2014-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $7.97M derived: sum of 2 quarters · filed 2017-03-28 | $10.71M derived: sum of 3 quarters · filed 2017-03-28 | $13.31M 10-K · filed 2017-03-28 | $13.31M 10-K · filed 2015-03-11 | $17.63M 10-K · filed 2015-03-11 | ||||||||
| 2014-09-30 | $2.57M 10-Q · filed 2015-11-09 | $2.57M 10-Q · filed 2014-11-10 | $5.31M derived: sum of 2 quarters · filed 2015-11-09 | $7.91M 10-Q · filed 2015-11-09 | $7.91M 10-Q · filed 2014-11-10 | $10.30M derived: sum of 4 quarters · filed 2016-03-29 | $12.23M 10-Q · filed 2014-11-10 | |||||||
| 2014-06-30 | $2.74M 10-Q · filed 2015-08-10 | $2.74M 10-Q · filed 2014-08-11 | $5.34M 10-Q · filed 2015-08-10 | $5.34M 10-Q · filed 2014-08-11 | $7.73M derived: sum of 3 quarters · filed 2016-03-29 | $8.88M derived: sum of 4 quarters · filed 2016-03-29 | $9.66M 10-Q · filed 2014-08-11 | |||||||
| 2014-03-31 | $2.60M 10-Q · filed 2015-05-08 | $4.99M derived: sum of 2 quarters · filed 2016-03-29 | $6.14M derived: sum of 3 quarters · filed 2016-03-29 | $6.73M derived: sum of 4 quarters · filed 2016-03-29 | $6.92M 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $3.54M derived: sum of 2 quarters · filed 2016-03-29 | $4.13M derived: sum of 3 quarters · filed 2016-03-29 | $4.32M 10-K · filed 2016-03-29 | $4.32M 10-K · filed 2014-03-17 | $4.32M 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | $1.15M 10-Q · filed 2014-11-10 | $1.74M derived: sum of 2 quarters · filed 2014-11-10 | $1.93M 10-Q · filed 2014-11-10 | $1.93M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $589.87K 10-Q · filed 2014-08-11 | $783.31K 10-Q · filed 2014-08-11 | $783.31K derived: sum of 3 quarters · filed 2015-03-11 | |||||||||||
| 2013-03-31 | $193.44K 10-Q · filed 2014-05-12 | $193.44K derived: sum of 2 quarters · filed 2015-03-11 | ||||||||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-11 | |||||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 |